Management of early ectopic pregnancy

Int J Gynaecol Obstet. 1994 Mar;44(3):239-44. doi: 10.1016/0020-7292(94)90173-2.

Abstract

Objective: Management of early ectopic pregnancy was investigated in a multicenter, prospective study.

Methods: Serum beta-hCG levels were monitored after therapy and correlated to the type of management, gestational age, and initial serum beta-hCG levels in 119 patients with ectopic pregnancies detected at 5-7 postmenstrual weeks.

Results: Salpingectomy was performed in 16 patients. No post-operative complications were reported. After conservative laparoscopic surgery of 51 ectopic pregnancies, 9 (18%) had delayed decrease or an increase of serum beta-hCG levels. Re-operations were performed in 4 (7%) patients. Similar findings were noted in 2/6 patients after conservative operations performed by laparotomy. Intrachorionic injection treatment was successful in 17/18 ectopic pregnancies, and expectant management in 7/8 patients with initial serum beta-hCG levels below 250 mIU/ml.

Conclusions: Persistence of trophoblastic activity is a potential complication of conservative surgical treatment of ectopic pregnancy. A detailed diagnosis as early as 6-7 post-menstrual weeks may be the key for future non-surgical management of ectopic pregnancy.

Publication types

  • Multicenter Study

MeSH terms

  • Abortifacient Agents / administration & dosage
  • Abortion, Therapeutic / methods
  • Biomarkers, Tumor / blood
  • Chorionic Gonadotropin / blood
  • Chorionic Gonadotropin, beta Subunit, Human
  • Chorionic Villi
  • Fallopian Tubes / surgery
  • Female
  • Humans
  • Methotrexate
  • Ornipressin
  • Peptide Fragments / blood
  • Pregnancy
  • Pregnancy Trimester, First
  • Pregnancy, Tubal / epidemiology
  • Pregnancy, Tubal / surgery
  • Pregnancy, Tubal / therapy*
  • Prospective Studies
  • Reoperation

Substances

  • Abortifacient Agents
  • Biomarkers, Tumor
  • Chorionic Gonadotropin
  • Chorionic Gonadotropin, beta Subunit, Human
  • Peptide Fragments
  • Ornipressin
  • Methotrexate